Artificial Intelligence: Applications in Pharmacovigilance Signal Management [0.03%]
人工智能在药物警戒信号管理中的应用
Jeffrey Warner,Anaclara Prada Jardim,Claudia Albera
Jeffrey Warner
Pharmacovigilance is the science of collection, detection, and assessment of adverse events associated with pharmaceutical products for the ongoing monitoring and understanding of those products' safety profiles. Part of this process, signa...
Challenges to Establishing Pharmaceutical Medicine as a Profession: Needs for Professional Identity and a Career Pathway: Role of Education and Training [0.03%]
建立医药行业作为职业的挑战:需要职业认同和职业发展路径:教育与培训的作用
Honorio Silva,Varvara Baroutsou,Domenico Criscuolo et al.
Honorio Silva et al.
Pharmaceutical Medicine (PM) was defined by its founding pharmaceutical physicians as a "medical/scientific discipline concerned with the discovery, development, evaluation, registration, monitoring, and medical aspects of the commercializa...
Shifting Paradigms in Medicines Development as a Profession: To Be or Not To Be [0.03%]
医药研发行业范式的转变:继续还是放弃?
Soneil Guptha,Domenico Criscuolo
Soneil Guptha
Importance of Health Economics and Outcomes Research in the Product Lifecycle [0.03%]
健康经济学和结果研究在产品生命周期中的重要性
Amit Dang
Amit Dang
Health economics and outcomes research (HEOR) has become an integral part of healthcare systems, through its ability to authentically demonstrate the value of the product. HEOR provides healthcare stakeholders with important insights to mak...
Cost and Duration of Clinical Trials in Drug Development by Japanese Pharmaceutical Companies [0.03%]
日本药企新药研发临床试验成本及周期分析研究
Norihiro Okada,Yosuke Takahashi
Norihiro Okada
Background: Understanding parameters such as cost and duration, which reflect the scale of clinical trials, is essential for government agencies to formulate pharmaceutical policies and for pharmaceutical companies to str...
Kayla R Mehl,Stephanie R Morain,Emily A Largent
Kayla R Mehl
This paper provides an overview of the ethical considerations surrounding the inclusion of underserved populations in later-phase clinical trials. Underserved populations, defined here as those with restricted access to or limited benefits ...
Correction: The Value and Importance of a Professional Ethical Code for Medicines Development: IFAPP International Ethics Framework [0.03%]
订正:药品开发专业伦理规范的价值和重要性:IFAPP国际道德框架
Sandor Kerpel-Fronius,Alexander L Becker;Members of the IFAPP Ethics Working Group
Sandor Kerpel-Fronius
Published Erratum
Pharmaceutical medicine. 2025 Mar 26. DOI:10.1007/s40290-025-00563-0 2025
Compliance with Cyproterone Contraindications and Meningioma Risk: Resource-Efficient Use of Aggregated Statistics from Swedish National Health Registers [0.03%]
与赛普替隆禁忌症的依从而及脑膜瘤的风险有关的高效利用来自瑞典国家健康登记表的综合统计资源
Karl Mikael Kälkner,Anders Sundström,Rickard Ljung
Karl Mikael Kälkner
Visionary Health Architects and Leaders: The Strategic Role of Medical Advisors in Modern Pharma [0.03%]
远见健康的建筑师和领导者:医疗顾问在现代制药中的战略角色
Selene García-García,Joan Rius-Tarruella
Selene García-García
This paper reviews the pivotal role of the Medical Advisor (MA) within the medical department of the pharmaceutical industry, highlighting their essential contribution to the development, commercialization, and appropriate use of medicines....
Pravin Chopra
Pravin Chopra
Medicines development has dramatically transformed in the preceding decades. It has evolved from a task undertaken by a small team to a complex series of activities, involving several functions and qualified professionals, across multiple, ...